|
¸íÁöº´¿ø ³»ºÐºñ³»°ú ÀÌ¹Î°æ ±³¼ö°¡ »ý¹°Çבּ¸Á¤º¸¼¾ÅÍ(BRIC/ Biological Research Information Center)°¡ ÁÖ°üÇÏ´Â ‘Çѱ¹À» ºû³»´Â »ç¶÷µé(ÇѺû»ç)’¿¡ ¼±Á¤µÆ´Ù. ¸íÁöº´¿øÀº ÀÌ¹Î°æ ±³¼ö°¡ ÃÖ±Ù ¹Ì±¹´ç´¢º´ÇÐȸ(ADA) °ø½Ä Àú³ÎÀÎ ‘Diabetes care’¿¡ ‘Á¦ 2Çü ´ç´¢º´ ȯÀÚ¿¡¼ SGLT-2 ¾ïÁ¦Á¦ »ç¿ë°ú ¸Á¸·Á¤¸ÆÆó¼âÀÇ À§Çèµµ(Sodium–Glucose Cotransporter 2 Inhibitors and Risk of Retinal Vein Occlusion Among Patients With Type 2 Diabetes: A Propensity Score–Matched Cohort Study)’ ³í¹®À» °ÔÀçÇÑ °ø·Î¸¦ ÀÎÁ¤¹Þ¾Æ ÇѺû»ç¿¡ ¼±Á¤µÆ´Ù°í 8ÀÏ ¹àÇû´Ù. BRICÀº »ý¸í°úÇкоßÀÇ ÇмúÁö °¡¿îµ¥ IF 10ÀÌ»óÀÇ ÇмúÁö¿¡ ³í¹®À» °ÔÀçÇÑ Çѱ¹ÀÎ °úÇÐÀÚ¸¦ ‘Çѱ¹À» ºû³»´Â »ç¶÷µé’·Î ¼±Á¤, µîÀçÇϰí ÀÖ´Ù.
. |